Related Experiment Videos
Targeting mRNA stability arrests inflammatory bone loss
Chetan S Patil1, Min Liu, Wenpu Zhao
1Department of Periodontics and Oral Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Abstract:
Many proinflammatory cytokines contain adenylate-uridylate-rich elements (AREs) within the 3'-untranslated region (UTR) that confer rapid mRNA destabilization. During the inflammatory response, cytokine mRNA are stabilized via complex interactions with RNA-binding proteins controlled by phosphorylation via multiple signaling pathways including the mitogen-activated protein kinases (MAPKs). In the absence of inflammation, a key cytokine-regulating RNA-binding protein, tristetraprolin (TTP), shuttles mRNA transcripts to degradation machinery in order to maintain low levels of inflammatory cytokines. Using this general model of mRNA decay, over expression of TTP was evaluated in an experimental model of inflammatory bone loss to determine whether altering cytokine mRNA stability has an impact in pathological bone resorption. Using adenoviral-delivered TTP, significant reductions of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and prostaglandin (PG)E(2) were observed in vitro through a mechanism consistent with targeting mRNA stability. In vivo analysis indicates a significant protective effect from inflammation-induced bone loss and inflammatory infiltrate in animals overexpressing TTP compared with reporter controls. These findings provide experimental evidence that mRNA stability is a valid therapeutic target in inflammatory bone loss.
Insights
Targeting messenger RNA (mRNA) stability by overexpressing tristetraprolin (TTP) reduced inflammatory cytokines and protected against inflammation-induced bone loss. This suggests mRNA stability is a viable therapeutic target for bone resorption disorders.
Area of Science:
- Molecular Biology
- Immunology
- Orthopedics
Background:
- Proinflammatory cytokines, regulated by mRNA stability, are implicated in inflammatory bone loss.
- Adenylate-uridylate-rich elements (AREs) in 3'-untranslated regions (UTRs) destabilize cytokine mRNA.
- Tristetraprolin (TTP) is a key RNA-binding protein that promotes mRNA decay, maintaining low cytokine levels.
Purpose of the Study:
- To investigate the therapeutic potential of targeting mRNA stability in inflammatory bone loss.
- To determine if overexpression of TTP impacts pathological bone resorption by altering cytokine mRNA stability.
Main Methods:
- Adenoviral delivery of TTP was used to overexpress the protein in an experimental model of inflammatory bone loss.
- In vitro analysis assessed the impact of TTP on interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and prostaglandin E2 (PGE2) levels.
- In vivo studies evaluated the protective effects of TTP overexpression against inflammation-induced bone loss and inflammatory infiltrate.
Main Results:
- In vitro, TTP overexpression significantly reduced IL-6, TNF-alpha, and PGE2, consistent with targeting mRNA stability.
- In vivo, animals overexpressing TTP showed significant protection from inflammation-induced bone loss.
- TTP overexpression also reduced inflammatory infiltrate in the in vivo model.
Conclusions:
- Altering cytokine mRNA stability through TTP overexpression demonstrates a significant protective effect in experimental inflammatory bone loss.
- These findings establish mRNA stability as a promising therapeutic target for managing pathological bone resorption associated with inflammation.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
RNA Stability
RNA Stability
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
MicroRNAs